Opportunity Information: Apply for RFA HD 16 015
Apply for RFA HD 16 015
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Postdoctoral Research Training in Pediatric Clinical Pharmacology and Therapeutics (T32)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Apr 20, 2015 and posted on Apr 20, 2015.
- Applicants must submit their applications by Jul 21, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $523,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments Public housing authorities/Indian housing authorities Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Postdoctoral Research Training in Pediatric Clinical Pharmacology and Therapeutics (T32) opportunity (Funding Opportunity Number RFA-HD-16-015) is a National Institutes of Health (NIH) institutional training grant aimed at building a strong pipeline of clinician-scientists who can become leaders in pediatric clinical pharmacology research. The main purpose is to support structured postdoctoral research training programs that give trainees deep, practical experience in both basic and clinical research methods as they relate to how medicines work in infants, children, and adolescents. A central expectation is that trainees will leave the program prepared to design and conduct rigorous pediatric pharmacology and therapeutics studies independently, positioning them to compete for future research funding and to contribute to safer, more effective medication use in pediatric populations.
This FOA falls under the discretionary grant category and uses the NIH T32 training mechanism, which means the award is made to an institution or organization rather than to an individual trainee. The applicant institution is responsible for proposing and running a comprehensive training environment, including mentorship, research opportunities, and a curriculum that covers the methodology and conduct of research relevant to pediatric clinical pharmacology. In practical terms, the program should be designed to develop clinician-scientists with the skills to bridge clinical care and research, including the ability to translate scientific insights into well-designed studies involving pediatric participants, and to interpret findings in ways that meaningfully inform pediatric therapeutics.
The funding is associated with CFDA number 93.865 (Child Health and Human Development Extramural Research), aligning the opportunity with the broader federal mission of improving child health through high-quality research and training. The estimated total funding amount listed is $523,000, and there is no cost-sharing or matching requirement, which means applicants are not required to provide non-federal matching funds as a condition of the award. The opportunity was posted on April 20, 2015, with an application due date of July 21, 2015, and an archive date of August 21, 2015, indicating it was a time-limited solicitation during that cycle.
Eligibility is broad and includes many types of U.S.-based institutions and organizations that can support a formal postdoctoral research training program. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (including small businesses and other for-profit entities), and various government entities such as state, county, city/township, special district governments, and independent school districts. The eligibility list also explicitly recognizes a wide range of mission-driven and community-serving institutions, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and eligible federal agencies. At the same time, the FOA makes clear that non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed, reinforcing that the training and supported activities must be domestically based under NIH rules.
Anyone seeking full details would have been directed to the official NIH announcement page (http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-16-015.html). For technical access issues, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, which is meant to help applicants who encounter problems opening the announcement or linking to the FOA materials. Overall, the opportunity is best understood as NIH support for institutions to build or strengthen dedicated postdoctoral training programs that produce independent pediatric clinical pharmacology researchers with strong foundations in both the science and the real-world conduct of pediatric clinical studies.
FAQs: Postdoctoral Research Training in Pediatric Clinical Pharmacology and Therapeutics (T32) - RFA-HD-16-015
What is the name of this grant opportunity?
The opportunity is titled Postdoctoral Research Training in Pediatric Clinical Pharmacology and Therapeutics (T32).
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-HD-16-015.
Which federal agency is offering this opportunity?
This is a National Institutes of Health (NIH) opportunity.
What type of grant mechanism is used?
The FOA uses the NIH T32 institutional training grant mechanism.
Is this an individual fellowship, or is it awarded to an organization?
It is an institutional award. The grant is made to an institution or organization, not to an individual trainee.
What is the main purpose of this T32 training program?
The main purpose is to support structured postdoctoral research training programs that build a strong pipeline of clinician-scientists who can become leaders in pediatric clinical pharmacology research.
What kinds of trainee experiences are expected under this FOA?
The program is expected to provide deep, practical training in basic and clinical research methods related to how medicines work in infants, children, and adolescents, within a structured environment that includes mentorship, research opportunities, and a relevant curriculum.
What is a central expectation for trainees completing the program?
A central expectation is that trainees will leave prepared to design and conduct rigorous pediatric pharmacology and therapeutics studies independently, positioning them to compete for future research funding and contribute to safer, more effective pediatric medication use.
What is the overarching focus area of the research training?
The focus is on pediatric clinical pharmacology and therapeutics, emphasizing the science and real-world conduct of research on medication use in pediatric populations.
What responsibilities does the applicant institution have under a T32?
The applicant institution is responsible for proposing and running a comprehensive training environment, including mentorship, research opportunities, and a curriculum covering the methodology and conduct of research relevant to pediatric clinical pharmacology.
What does the FOA mean by bridging clinical care and research?
In practical terms, the training should develop clinician-scientists who can translate scientific insights into well-designed studies involving pediatric participants and interpret findings in ways that meaningfully inform pediatric therapeutics.
What grant category does this opportunity fall under?
This FOA falls under the discretionary grant category.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.865 (Child Health and Human Development Extramural Research).
How much funding is listed for this opportunity?
The estimated total funding amount listed is $523,000.
Is cost-sharing or matching required?
No. The FOA states there is no cost-sharing or matching requirement, meaning non-federal matching funds are not required as a condition of the award.
When was this opportunity posted?
The opportunity was posted on April 20, 2015.
What was the application due date?
The application due date was July 21, 2015.
When was the archive date?
The archive date was August 21, 2015.
Does the timeline indicate this was a time-limited solicitation?
Yes. The posted date, due date, and archive date indicate this was a time-limited solicitation during that cycle.
Who is eligible to apply?
Eligibility is broad and includes many types of U.S.-based institutions and organizations that can support a formal postdoctoral research training program, including:
- Public and private institutions of higher education
- Nonprofit organizations (including those with and without 501(c)(3) status)
- For-profit organizations (including small businesses and other for-profit entities)
- Government entities (state, county, city/township, special district governments, and independent school districts)
- Faith-based or community-based organizations
- Eligible federal agencies
Are minority-serving institutions explicitly recognized as eligible?
Yes. The eligibility list explicitly recognizes several mission-driven and community-serving institution types, including:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-serving Institutions
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
Are non-U.S. (foreign) entities eligible to apply?
No. The FOA states that non-U.S. entities are not eligible to apply.
Are non-U.S. components of U.S. organizations eligible?
No. The FOA states that non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed under this FOA?
No. The FOA states that foreign components (as defined by NIH policy) are not allowed.
Where can someone find the official NIH announcement page for full details?
The FOA directs readers to the official NIH announcement page at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-16-015.html
Who should be contacted for technical access issues with the FOA page?
For technical access issues (such as problems opening the announcement or linking to materials), the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What is the overall goal of the program in terms of workforce development?
Overall, the program is intended to help institutions build or strengthen dedicated postdoctoral training programs that produce independent pediatric clinical pharmacology researchers with strong foundations in both the science and the real-world conduct of pediatric clinical studies.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Womens Business Center Initial Grant
Previous opportunity: RESTORE Act Centers of Excellence Research Grants Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 16 015
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 16 015) also looked into and applied for these:
| Funding Opportunity |
|---|
| Studies at Periviable Gestation (R03) Apply for PA 15 199 Funding Number: PA 15 199 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Studies at Periviable Gestation (R01) Apply for PA 15 200 Funding Number: PA 15 200 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Studies at Periviable Gestation (R21) Apply for PA 15 198 Funding Number: PA 15 198 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| National Centers for Translational Research in Reproduction and Infertility (P50) Apply for RFA HD 16 010 Funding Number: RFA HD 16 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,200,000 |
| Non or Minimally Invasive Methods to Measure Biochemical Substances for Neonatal and Perinatal Clinical Care and Research (R41) Apply for RFA HD 16 028 Funding Number: RFA HD 16 028 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Bioengineering Research Partnership (BRP) Non or Minimally Invasive Methods to Measure Biochemical Substances during Neonatal and Perinatal Patient Care and Research (R01) Apply for PAR 15 285 Funding Number: PAR 15 285 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| HIV infected Adolescents Transitioning from Pediatric to the Adult Care Settings (R01) Apply for RFA HD 16 033 Funding Number: RFA HD 16 033 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| HIV infected Adolescents Transitioning from Pediatric to the Adult Care Settings (R21) Apply for RFA HD 16 034 Funding Number: RFA HD 16 034 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Secondary Analysis of Existing Databases in Traumatic Brain Injury to Explore Outcomes Relevant to Medical Rehabilitation (R21) Apply for RFA HD 16 001 Funding Number: RFA HD 16 001 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Neurodevelopmental Assessment of Infants and Children in Resource Limited Settings (R43/R44) Apply for RFA HD 16 024 Funding Number: RFA HD 16 024 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Neurodevelopmental Assessment of Infants and Children in Resource Limited Settings (R41/R42) Apply for RFA HD 16 025 Funding Number: RFA HD 16 025 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Mechanisms of Human Structural Birth Defects (P01) Apply for RFA HD 16 009 Funding Number: RFA HD 16 009 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Pelvic Floor Disorders Network Clinical Sites (UG1) Apply for RFA HD 16 012 Funding Number: RFA HD 16 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $180,000 |
| Pelvic Floor Disorders Network Data Coordinating Center (U24) Apply for RFA HD 16 011 Funding Number: RFA HD 16 011 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Biomedical and Behavioral Research Innovations to Ensure Equity (BRITE) in Maternal and Child Health (R15) Apply for PAR 15 319 Funding Number: PAR 15 319 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Tools for Assessment and Improvement of Neurologic Outcomes (R41/R42) Apply for RFA HD 16 006 Funding Number: RFA HD 16 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Tools for Assessment and Improvement of Neurologic Outcomes (R43/R44) Apply for RFA HD 16 007 Funding Number: RFA HD 16 007 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| CAPSTONE Centers for Multidisciplinary Research and Training in Child Abuse and Neglect (P50) Apply for RFA HD 16 002 Funding Number: RFA HD 16 002 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Mechanisms of Adverse Drug Effects in Children (R01) Apply for PAR 08 248 Funding Number: PAR 08 248 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Mechanisms of Adverse Drug Reactions in Children (R03) Apply for PAR 08 249 Funding Number: PAR 08 249 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 16 015", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.